Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Multifocal Atrial Tachycardia, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Cardiac Ablation, and Tissue Biopsy.

Dr. Agee is medical director for the Bayview Medical Offices. Her practice includes all aspects of primary care medicine, including prevention, pap smears and cortisone shots. Dr. Agee is from Annapolis. She attended Wake Forest University School of Medicine, in North Carolina, trained in general internal medicine at Johns Hopkins Bayview Medical Center. Dr. Agee is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Type 2 Diabetes (T2D).

Robert Benitez is a Cardiologist in Baltimore, Maryland. Dr. Benitez is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Mitral Valve Regurgitation, Necrosis, Cardiogenic Shock, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Dr. Stephen D. Sisson is a professor of medicine at the Johns Hopkins University School of Medicine. Dr. Sisson’s area of clinical expertise is internal medicine. He serves as vice president of clinical operations for the Office of Johns Hopkins Physicians, and as director of the Johns Hopkins Physician Education and Assessment Center (PEAC). He is the Philip A. Tumulty Professor of Medicine. Dr. Sisson holds a B.S. in chemistry from Duke University. He earned his M.D. (Alpha Omega Alpha, with research honors) at Tufts University School of Medicine. He completed an internal medicine internship and residency at Johns Hopkins, serving as assistant chief of service for the Barker Firm. He joined the Johns Hopkins faculty in 1996. He served for 15 years as the associate director of the Osler Medical Housestaff Training Program. His research interests include community outreach, medical education and ambulatory care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sisson is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are COVID-19, Cerebral Palsy, Acute Eosinophilic Pneumonia, and Hypereosinophilic Syndrome.

Dr. Bimal H. Ashar is a Professor of Clinical Medicine at the Johns Hopkins University School of Medicine. He serves as the Interim Director of the Division of General Internal Medicine, Clinical Director of the Division of General Internal Medicine, and Director of the Executive & Preventive Health Program. Named one of the “Best Doctors in America”, Dr. Ashar’s primary research interests include preventive medicine, dietary supplements and medical education, and he has authored numerous book chapters and articles on these topics. Dr. Ashar is also an editor of The Johns Hopkins Internal Medicine Board Review book and a former consulting editor for the Medical Clinics of North America. Dr. Ashar is an active member of the Society of General Internal Medicine and has served as president for the mid-Atlantic region. He is also a fellow of the American College of Physicians. He obtained his medical degree from the University of Maryland School of Medicine. He completed his residency in internal medicine at Case Western Reserve University/University Hospitals of Cleveland. He subsequently became chief resident and a faculty member at Case Western. Dr. Ashar left Cleveland in 1998 and joined the faculty in the Division of General Internal Medicine at Johns Hopkins University. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida and has active medical licenses in Maryland and Washington, D.C.. Videos 2017 Excellence in Service and Professionalism Award - Bimal Ashar, M.D., The Johns Hopkins Hospital Recent News Articles and Media Coverage Young MDs Hazy on Dietary Supplements, Wall Street Journal, May 14, 2007. Dr. Ashar is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Mevalonate Kinase Deficiency, Hypertension, Brugada Syndrome, and Short QT Syndrome.

Dr. Daniel Ford is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in psychiatry and behavioral sciences and, at the Johns Hopkins Bloomberg School of Public Health, in health policy and management and in epidemiology. Dr. Ford serves as the director of the Institute for Clinical and Translational Research and the senior associate dean for clinical and translational research at the Johns Hopkins School of Medicine. Widely regarded as a pioneer in research associated with the interrelationships between mental disorders and chronic medical conditions, Dr. Ford gained international acclaim for clinical studies documenting depression as an independent risk factor for coronary heart disease and for research describing the long-term health risks related to sleep disturbances. He was chosen by the Robert Wood Johnson Foundation to direct the evaluation of its $12 million Depression in Primary Care Initiative. He also has been the principal researcher on a large training grant to develop researchers in general internal medicine. A leader in using the Internet for clinical research, Dr. Ford worked closely with Johns Hopkins personnel who developed e-IRB, an electronic process for submitting research proposals to the school of medicine’s Institutional Review Board, which oversees requests to launch clinical studies. His research interests include ways to improve the treatment of chronic diseases through information technology. He also advocates treating human research subjects as partners, ensuring that they receive sufficient thanks for their commitment and willingness to contribute to scientific progress. Dr. Ford received his M.D. from the State University of New York at Buffalo in 1982. He arrived at Hopkins that year as a medical resident and, except for a brief period as a National Institutes of Health fellow, has been on the Johns Hopkins faculty ever since. He received his master’s degree in public health from the Bloomberg School in 1986. He has published more than 120 research papers and book chapters, and was associate editor of the Journal of General Internal Medicine and a member of the editorial board of General Hospital Psychiatry. Dr. Ford is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are COVID-19, Stroke, Hypertension, Maturity Onset Diabetes of the Young, and Thrombectomy.

Dr. Brent Petty is a Professor of Medicine at the Johns Hopkins University School of Medicine. He holds a secondary appointment in Pharmacology and Molecular Sciences. Dr. Petty’s areas of expertise include clinical pharmacology and general internal medicine. He received his M.D. from the University of Utah. Dr. Petty’s research interests include quality improvement, antimicrobial chemotherapy, hospital-based medical practices, and internal medicine with ophthalmologic clinical trials. At Johns Hopkins, Dr. Petty serves as chair of the Pharmacy and Therapeutics Committee, the Clinical Quality Improvement Committee, the Continuity of Care Subcommittee. He co-chairs the Utilization Review Committee and the Order Set Review Committee. He is a member of the Society of General Internal Medicine. Dr. Petty is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Juvenile Temporal Arteritis.

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease.

Ashok Chopra is a Cardiologist in Halethorpe,, Maryland. Dr. Chopra is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Dilated Cardiomyopathy (DCM), and Heart Failure.

Stephen Gottlieb is a Cardiologist in Baltimore,, Maryland. Dr. Gottlieb is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

David Kim is a Cardiologist in Baltimore,, Maryland. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Atherosclerosis, and Coronary Heart Disease.

Emily Carper is a primary care provider, practicing in Family Medicine in Baltimore, Maryland. Dr. Carper is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Obesity, Maturity Onset Diabetes of the Young, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Michael Kelemen is a general cardiologist for the Johns Hopkins Heart and Vascular Institute in the Department of Medicine. His research in cardiac rehabilitation demonstrated the power of exercise as a treatment for hypertension, high cholesterol, and recovery from cardiac events. Dr. Kelemen is an associate professor of medicine in the Johns Hopkins School of Medicine. Dr. Kelemen received his medical degree from the University of Pennsylvania Health System School of Medicine. He completed his residency in medicine at University Hospitals of Cleveland, and pursued cardiology fellowships at the University of California, San Francisco School of Medicine and at the Wyman Park Health System in Baltimore. Dr. Kelemen is active in community health issues, having served on the boards of the Health Alliance and The Horizon Foundation, which provide medical and mental health services to underserved populations. As the founding medical director of the Prescribed Active Cardiac Exercises (PACE) program at Catonsville Community College in 1976, he performed the research that demonstrated the benefits of exercise for cardiac patients. Dr. Kelemen is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Heart Attack, Apoplexy, Postural Orthostatic Tachycardia Syndrome (POTS), and Short QT Syndrome.

Maurizio Colognesi is a Cardiologist in Baltimore, Maryland. Dr. Colognesi is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Pulmonary Edema, Heart Failure, Heart Attack, and Apoplexy.

Dr. Thomas R. Aversano is an associate professor of medicine at Johns Hopkins University. He is also the associate chief of cardiology at Johns Hopkins Cardiology at GBMC and the director of the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). His research interests focus on health services research - public policy, cardiovascular disease treatment, coronary intervention, and patient outcomes research in cardiovascular disease. Dr. Aversano received an undergraduate degree from the University of Rochester and a medical degree from the University of Oklahoma. He was a resident of internal medicine as well as a research fellow in cardiology at S.U.N.Y. at Buffalo before joining Johns Hopkins University as a cardiology fellow in 1982. Dr. Aversano has contributed to Johns Hopkins InHealth, specifically the development of a cardiology program (inCar) within the InHealth initiative focused on creation of a real-time decision-support, communication, and documentation tool for interventional cardiology. He also created and leads the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT) whose projects have involved 87 hospitals in 11 States and recruited more than 30,000 patients in randomized trials and registries. C-PORT worked with Departments of Health in 13 States to perform these studies. These projects were instrumental in changing both national heart association guidelines and State health care policy regarding performance of percutaneous coronary intervention (PCI). Dr. Aversano is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Familial Ventricular Tachycardia, Transient Ischemic Attack (TIA), Inappropriate Sinus Tachycardia (IST), Arrhythmias, and Percutaneous Coronary Intervention (PCI).

Dr. Michael Fingerhood is a professor of medicine and public health at the Johns Hopkins University. His areas of clinical expertise include addiction medicine and internal medicine. He earned his M.D. from the Albert Einstein College of Medicine of Yeshiva University. He completed his residency at Johns Hopkins. Dr. Fingerhood's research interests include substance use disorders, contingency management, hepatitis C and HIV. He is a member of several professional organizations, including the American Society of Addiction Medicine, the American Academy of HIV Medicine, The Society of General Internal Medicine and the American College of Physicians. Dr. Fingerhood is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Opioid Use Disorder, HIV/AIDS, Myelitis, and AIDS Dysmorphic Syndrome.

Dr. Jessica Colburn is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. Her area of clinical expertise is geriatric medicine. She earned her M.D. from University of Pittsburgh School of Medicine. She completed her residency in internal medicine at Johns Hopkins Bayview Medical Center and performed a fellowship in geriatric medicine and gerontology at Johns Hopkins. Dr. Colburn’s clinical and educational research is focused on primary care of older adults and teaching learners to care for older adults. Dr. Colburn is the Fellowship Program Director of the Johns Hopkins Geriatrics Fellowship. She also is the principal investigator of the Johns Hopkins Geriatric Workforce Enhancement Program, an educational initiative in geriatrics at Johns Hopkins aimed to improve primary care of older adults living in the community through partnerships with primary care and community-based organizations that serve older adults. In addition, Dr. Colburn is the Co-Director of the Johns Hopkins Topics in Geriatric Medicine Course; and precepts and mentors medical students, residents and fellows. In 2015, she was recognized with the Lisa J. Heiser Award for Junior Faculty Contribution in Education from the Johns Hopkins Institute for Excellence in Education. She also was selected for the Faculty Teaching Excellence Award by the Johns Hopkins Bayview internal medicine residents in both 2020 and 2021. Dr. Colburn is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Coronary Heart Disease, Atherosclerosis, Multiple Endocrine Neoplasia Type 2, and Dementia.

An associate professor of medicine, and the L. Douglas Lee and Barbara Levinson-Lee Professorship in Clinical Practice, Steven J. Kravet, M.D., M.B.A., serves as president of the largest primary care group in Maryland, Johns Hopkins Community Physicians; a network of suburban community practices that serves more than 900,000 patients annually at more than 40 locations throughout Maryland, Washington, D.C., and Northern Virginia. A third-generation pharmacist and community health care advocate who prizes the relationships that develop between patients and care-givers, Dr. Kravet has spent more than two decades at Johns Hopkins Bayview Medical Center, providing strong leadership in a wide variety of community health services. Before being named president of Johns Hopkins Community Physicians in 2009, Dr. Kravet served as medical director of inpatient medical services, internal medicine and ambulatory services, as well as chief medical officer for quality and patient safety, and deputy director for clinical activity in the Department of Medicine at Johns Hopkins Bayview Medical Center. As a member of the faculty in the Division of General Internal Medicine, he has obtained invaluable insights into the practical realities of primary care. Having earned an M.B.A. in Johns Hopkins’ Business of Medicine program, he has an excellent understanding of the business issues affecting outpatient care. The American College of Physicians has used Dr. Kravet’s research on primary care processes to formulate plans for redesigning health care practices. After receiving his pharmacist degree from the Rutgers University College of Pharmacy in 1988, Dr. Kravet ran his family’s pharmacy in Spotswood, N.J., until 1992, during which time he worked on obtaining his medical degree from the Robert Wood Johnson Medical School. He arrived at Johns Hopkins Bayview as a resident in 1992 and has spent his entire career at Johns Hopkins. Among his honors are the Resident Teaching Award and the Department of Medicine Chairman’s Award. Dr. Kravet practices all aspects of primary care medicine, including prevention and cortisone shots. Dr. Kravet is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Tinea Versicolor.

Graduated with honors from Baylor College of Medicine in 1978, Internship and Residency in Internal Medicine at the University of Alabama Teaching Hospitals (1979 - 1981), Masters of Business Administration from the Johns Hopkins Carey Business School in 2007. Private practice of Internal Medicine in Columbia, SC until joining faculty in the Division of Geriatric Medicine and Gerontology in 1995. Clinical concentration on caring for older adults with complex health needs in the office and hospital settings. Academic concentration on teaching, program development in education and clinical care. Roles in the Division included Fellowship Program Director (2003 - 2006), Clinical Director and Director of Education (2004 - 2008), Interim Director of the Division (2008 - 2009) and Director, Division of Geriatric Medicine and Gerontology. In 2020 became Executive Vice Chair for the Department of Medicine, Johns Hopkins University, and 2021 Director of the Department of Medicine for the Johns Hopkins Bayview Medical Center, both positions he holds currently. Videos Meet Our Expert: Dr. Samuel Christopher Durso Contact for Research Inquiries 5200 Eastern Avenue Mason F Lord Building Baltimore, MD 21224. Dr. Durso is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Acquired Ichthyosis, Dementia, Behcet Disease, and Glucocorticoid-Remediable Aldosteronism.

Robert Mills, D.O., joins Johns Hopkins Community Physicians with many years of experience as a family medicine physician. He grew up in New Jersey and attended Villanova University for his bachelors of science in biological sciences. Upon completion, he earned his doctor of osteopathic medicine from Philadelphia College of Osteopathic Medicine. As a provider, he finds it rewarding to get to know his patients on a more personal level and help them manage their health throughout their lives. He understands medicine is challenging on both sides - for his patients and as a provider - and he knows that providing a comfortable environment, where patients feel heard and respected, is what makes a good patient-physician relationship. Dr. Mills lives with his wife in Canton and has one too many pets, including four cats and a dog. Dr. Mills is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Combined Hyperlipidemia.